GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United Kingdom)

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlaxoSmithKline (United Kingdom), United Kingdom, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

44%


Total
Publications

20K


Total Open
Publications

8.7K


Total
Citations

962K


Open Access
Percentage

44%


Total
Publications

20K


Total Open
Publications

8.7K


Total
Citations

962K

Wikipedia

Website

Download

Breakdown

13% 20% 11% 56%

Publisher Open

13%

Both

20%

Other Platform Open

11%

Closed

56%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01002003004005006007008009001k1.1k1.2kTotal Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

2K

Hybrid 37%

2.4K

No Guarantees 34%

2.2K

Other Platform Open

Domain 79%

4.9K

Institution 43%

2.7K

Public 12%

723

Other Internet 5%

328

Preprint 4%

217

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
4.9K
Europe PMC
Domain
4.2K
Semantic Scholar
Public
621
University College London - UCL Discovery
Institution
448
Imperial College London - Spiral
Institution
218
University of Oxford - Oxford University Research Archive (ORA)
Institution
171
University of Cambridge - Apollo
Institution
160
University of Edinburgh - Edinburgh Research Explorer
Institution
158
University of Strathclyde - Strathprints: The University of Strathclyde institutional repository
Institution
153
Figshare
Public
136
1 / 21

Data updated 27 September 2022

Share

Share

Share